phillyvoice.com

A new test could save arthritis patients time, money and pain – but will it be used?

SAN DIEGO — Erinn Maury knew Remicade wasn't the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte's swollen, painful ...
Oregonian

New blood test, PrismRA, may herald improved care for patients with rheumatoid arthritis if insurers sign on

SAN DIEGO — Erinn Maury knew Remicade wasn’t the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte’s swollen, painful ...
Washington Examiner

AstraZeneca falls as RA drug underperforms Humira

WASHINGTON (AP) — Shares of AstraZeneca and its partner Rigel Pharmaceuticals Inc. fell Thursday after the companies reported that their experimental rheumatoid arthritis drug was less effective than ...
Seeking Alpha

RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed ...

NORTH CHICAGO, Ill., Oct. 20, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced positive topline results from the Phase 3b/4 head-to-head SELECT-SWITCH study evaluating the efficacy and safety of ...
MedPage Today

Xeljanz Edges Humira Just a Bit for Real-World RA Patients, Study Suggests

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Tofacitinib ...
FiercePharma

PREMIER Eight-Year and DE019 10-Year Data Presented at ACR 2011

ABBOTT PARK, Ill., Nov. 6, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced results from long-term open-label extensions of the PREMIER and DE019 Phase 3 studies, which evaluated HUMIRA® ...
Yahoo

Cigna to remove AbbVie's Humira from some drug reimbursement lists next year

(Reuters) - Cigna said on Monday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less pricey ...
Becker's Hospital Review

Congress: AbbVie exploited its Humira, Imbruvica patents

AbbVie has been accused of exploiting the country’s patent system to drive up prices for its rheumatoid arthritis drug Humira and cancer drug Imbruvica by the U.S. House Committee on Oversight and ...
Medical News Today

Humira interactions: Alcohol, medications, and other factors

As with other medications, Humira can interact with certain other drugs. It can also interact with some vaccines. An interaction occurs when one substance causes another substance to have a different ...
WebMD

Crohn's Disease: What Makes Biologic Treatments 'Interchangeable'

The FDA recently designated Yuflyma as "interchangeable" with the popular biologic Humira for the treatment of Crohn's disease and ulcerative colitis, two types of inflammatory bowel disease (IBD), ...
NPR

A new test could save arthritis patients time, money and pain. But will it be used?

SAN DIEGO — Dr. Erinn Maury knew Remicade wasn't the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte's swollen, painful ...